Sensitivity of Lipid Metabolism and Insulin Signaling to Genetic Alterations in Hepatic Peroxisome Proliferator–Activated Receptor-\(\gamma\) Coactivator-1\(\alpha\) Expression

DSpace/Manakin Repository

Sensitivity of Lipid Metabolism and Insulin Signaling to Genetic Alterations in Hepatic Peroxisome Proliferator–Activated Receptor-\(\gamma\) Coactivator-1\(\alpha\) Expression

Citable link to this page

 

 
Title: Sensitivity of Lipid Metabolism and Insulin Signaling to Genetic Alterations in Hepatic Peroxisome Proliferator–Activated Receptor-\(\gamma\) Coactivator-1\(\alpha\) Expression
Author: Kahn, Mario; Cooper, Marcus P.; Wu, Michele K.; Laznik, Dina; Qu, Lishu; Shulman, Gerald I.; Estall, Jennifer Lynn; Fisher, FFolliott Martin; Cohen, David Earl; Spiegelman, Bruce Michael

Note: Order does not necessarily reflect citation order of authors.

Citation: Estall, Jennifer L., Mario Kahn, Marcus P. Cooper, Ffolliott Martin Fisher, Michele K. Wu, Dina Laznik, Lishu Qu, David E. Cohen, Gerald I. Shulman, and Bruce M. Spiegelman. 2009. Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator–activated receptor-\(\gamma\) coactivator-1\(\alpha\) expression. Diabetes 58(7): 1499-1508.
Full Text & Related Files:
Abstract: Objective: The peroxisome proliferator–activated receptor-\(\gamma\) coactivator (PGC)-1 family of transcriptional coactivators controls hepatic function by modulating the expression of key metabolic enzymes. Hepatic gain of function and complete genetic ablation of PGC-1\(\alpha\) show that this coactivator is important for activating the programs of gluconeogenesis, fatty acid oxidation, oxidative phosphorylation, and lipid secretion during times of nutrient deprivation. However, how moderate changes in PGC-1\(\alpha\) activity affect metabolism and energy homeostasis has yet to be determined. Research Design and Methods: To identify key metabolic pathways that may be physiologically relevant in the context of reduced hepatic PGC-1\(\alpha\) levels, we used the Cre/Lox system to create mice heterozygous for PGC-1\(\alpha\) specifically within the liver (LH mice). Results: These mice showed fasting hepatic steatosis and diminished ketogenesis associated with decreased expression of genes involved in mitochondrial \(\beta\)-oxidation. LH mice also exhibited high circulating levels of triglyceride that correlated with increased expression of genes involved in triglyceride-rich lipoprotein assembly. Concomitant with defects in lipid metabolism, hepatic insulin resistance was observed both in LH mice fed a high-fat diet as well as in primary hepatocytes. Results: These data highlight both the dose-dependent and long-term effects of reducing hepatic PGC-1\(\alpha\) levels, underlining the importance of tightly regulated PGC-1\(\alpha\) expression in the maintenance of lipid homeostasis and glucose metabolism.
Published Version: doi://10.2337/db08-1571
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2699879/pdf/
Terms of Use: This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAA
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:10140028
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters